These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

300 related articles for article (PubMed ID: 35255968)

  • 1. Angiopoietin-2/-1 ratios and MMP-3 levels as an early warning sign for the presence of giant cell arteritis in patients with polymyalgia rheumatica.
    van Sleen Y; Therkildsen P; Nielsen BD; van der Geest KSM; Hansen I; Heeringa P; Posthumus MD; Sandovici M; Toonen EJM; Zijlstra J; Boots AMH; Hauge EM; Brouwer E
    Arthritis Res Ther; 2022 Mar; 24(1):65. PubMed ID: 35255968
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High angiopoietin-2 levels associate with arterial inflammation and long-term glucocorticoid requirement in polymyalgia rheumatica.
    van Sleen Y; Boots AMH; Abdulahad WH; Bijzet J; Sandovici M; van der Geest KSM; Brouwer E
    Rheumatology (Oxford); 2020 Jan; 59(1):176-184. PubMed ID: 31292652
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Diagnostic accuracy of serum biomarkers to identify giant cell arteritis in patients with polymyalgia rheumatica.
    Ramon A; Greigert H; Goueslard K; Cladière C; Ciudad M; Ornetti P; Audia S; Maillefert JF; Bonnotte B; Samson M
    RMD Open; 2024 Aug; 10(3):. PubMed ID: 39122253
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Leukocyte Dynamics Reveal a Persistent Myeloid Dominance in Giant Cell Arteritis and Polymyalgia Rheumatica.
    van Sleen Y; Graver JC; Abdulahad WH; van der Geest KSM; Boots AMH; Sandovici M; Brouwer E
    Front Immunol; 2019; 10():1981. PubMed ID: 31507597
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MMP-3 can distinguish isolated PMR from PMR with GCA: A retrospective study regarding PMR and GCA in Japan.
    Fukui S; Nunokawa T; Kobayashi S; Kamei S; Yokogawa N; Takizawa Y; Shimada K; Sugii S; Setoguchi K
    Mod Rheumatol; 2016; 26(2):259-64. PubMed ID: 26156043
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymyalgia rheumatica and giant cell arteritis in older patients: diagnosis and pharmacological management.
    Schmidt J; Warrington KJ
    Drugs Aging; 2011 Aug; 28(8):651-66. PubMed ID: 21812500
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Circulating CD8+ T cells in polymyalgia rheumatica and giant cell arteritis: a review.
    Martinez-Taboada VM; Blanco R; Fito C; Pacheco MJ; Delgado-Rodriguez M; Rodriguez-Valverde V
    Semin Arthritis Rheum; 2001 Feb; 30(4):257-71. PubMed ID: 11182026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum markers associated with disease activity in giant cell arteritis and polymyalgia rheumatica.
    van der Geest KS; Abdulahad WH; Rutgers A; Horst G; Bijzet J; Arends S; Roffel MP; Boots AM; Brouwer E
    Rheumatology (Oxford); 2015 Aug; 54(8):1397-402. PubMed ID: 25724206
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolic features and glucocorticoid-induced comorbidities in patients with giant cell arteritis and polymyalgia rheumatica in a Dutch and Danish cohort.
    Esen I; Arends S; Dalsgaard Nielsen B; Therkildsen P; Hansen I; van 't Ende A; Heeringa P; Boots A; Hauge E; Brouwer E; van Sleen Y
    RMD Open; 2023 Jan; 9(1):. PubMed ID: 36631159
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Aberrant phenotype of circulating antigen presenting cells in giant cell arteritis and polymyalgia rheumatica.
    Reitsema RD; Hesselink BC; Abdulahad WH; van der Geest KSM; Brouwer E; Heeringa P; van Sleen Y
    Front Immunol; 2023; 14():1201575. PubMed ID: 37600779
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Polymyalgia rheumatica in biopsy proven giant cell arteritis does not constitute a different subset but differs from isolated polymyalgia rheumatica.
    González-Gay MA; García-Porrúa C; Vázquez-Caruncho M
    J Rheumatol; 1998 Sep; 25(9):1750-5. PubMed ID: 9733456
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polymyalgia Rheumatica and Giant Cell Arteritis: A Systematic Review.
    Buttgereit F; Dejaco C; Matteson EL; Dasgupta B
    JAMA; 2016 Jun; 315(22):2442-58. PubMed ID: 27299619
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biomarkers in the era of targeted therapy in giant cell arteritis and polymyalgia rheumatica: is it possible to replace acute-phase reactants?
    Carvajal Alegria G; Nicolas M; van Sleen Y
    Front Immunol; 2023; 14():1202160. PubMed ID: 37398679
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Plasma adrenomedullin levels in patients with polymyalgia rheumatica and giant cell arteritis.
    Garcia-Unzueta MT; Martínez-Taboada VM; Amado-Señarís JA; Rodríguez-Valverde V
    Clin Exp Rheumatol; 2006; 24(2 Suppl 41):S6-9. PubMed ID: 16859588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. COVID-19 outcomes in giant cell arteritis and polymyalgia rheumatica versus rheumatoid arthritis: A national, multicenter, cohort study.
    Vieira M; Comarmond C; Labreuche J; Mirouse A; Saadoun D; Richez C; Flipo RM; Hachulla E; Drumez E; Cacoub P;
    J Autoimmun; 2022 Oct; 132():102868. PubMed ID: 35926375
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Accuracy of self-reported diagnoses of polymyalgia rheumatica and giant cell arteritis in the French prospective E3N- EPIC cohort: A validation study.
    Barde F; Ascione S; Pacoureau L; Macdonald C; Salliot C; Boutron-Ruault MC; Seror R; Nguyen Y
    Semin Arthritis Rheum; 2024 Feb; 64():152298. PubMed ID: 38000317
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Polymyalgia rheumatica shows metabolomic alterations that are further altered by glucocorticoid treatment: Identification of metabolic correlates of fatigue.
    Manning JE; Harris E; Mathieson H; Sorensen L; Luqmani R; McGettrick HM; Morgan AW; Young SP; Mackie SL
    J Autoimmun; 2024 Jul; 147():103260. PubMed ID: 38797046
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Concurrent baseline diagnosis of giant cell arteritis and polymyalgia rheumatica - A systematic review and meta-analysis.
    Nielsen AW; Frølund LL; Våben C; Bonde AR; Gormsen LC; de Thurah AL; Hauge EM; Keller KK
    Semin Arthritis Rheum; 2022 Oct; 56():152069. PubMed ID: 35858507
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Subclinical giant cell arteritis in polymyalgia rheumatica: Concurrent conditions or a common spectrum of inflammatory diseases?
    Salvarani C; Padoan R; Iorio L; Tomelleri A; Terrier B; Muratore F; Dasgupta B
    Autoimmun Rev; 2024 Jan; 23(1):103415. PubMed ID: 37625672
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Management of difficult polymyalgia rheumatica and giant cell arteritis: Updates for clinical practice.
    Lally L; Spiera R
    Best Pract Res Clin Rheumatol; 2018 Dec; 32(6):803-812. PubMed ID: 31427056
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.